Check out Apmonia Therapeutics’ press release on the company’s corporate organization and i-Lab innovation award.
#deeptech #biotech #cancer #reims
Apmonia Tx Press release
i-Lab 2020 Award
We feel very honored to be recipient of the i-Lab 2020 award. Support given to our ambitious project by Ministère de l’Enseignement Supérieur et de la Recherche (France) and Bpifrance will help developing Apmonia Therapeutics‘ innovative technology for the treatment of orphan oncology diseases.
Cancer Biology and Basic Sciences
We are thrilled to announce that Institut national du cancer (INCa) will provide financial support to a unique industry-academic R&D partnership gathering together Apmonia Therapeutics, MEDyC unit (CNRS UMR7369, Université de Reims Champagne-Ardenne, Prof. Stephane Dedieu, PI) and Gustave Roussy Cancer Center (INSERM U981, Dr. Alexandra Leary).
As part of the “Cancer Biology and Basic Sciences” 2020 call for proposals, our ambitious project aims at opening new therapeutic perspectives for the treatment of ovarian cancer, one of the highest unmet medical needs in oncology.
more :
https://www.e-cancer.fr/Institut-national-du-cancer/Appels-a-projets/Appels-a-projets-resultats/PLBIO-2020